9-Oct-2026
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Seeking Alpha News (Wed, 7-Oct 2:35 PM ET)
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Stryker (SYK)
TipRanks (Wed, 7-Oct 10:00 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Wed, 7-Oct 6:50 AM ET)
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and ANI Pharmaceuticals (ANIP)
TipRanks (Tue, 6-Oct 11:00 AM ET)
Market Chameleon (Tue, 6-Oct 4:40 AM ET)
Stryker announces leadership changes
Seeking Alpha News (Tue, 6-Oct 8:29 AM ET)
Stryker Announces CEO Succession and Leadership Transition
TipRanks (Tue, 6-Oct 8:28 AM ET)
Stryker announces leadership succession
Globe Newswire (Tue, 6-Oct 8:00 AM ET)
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
PRNewswire (Thu, 1-Oct 2:21 PM ET)
Stryker to announce third quarter 2026 financial results
Globe Newswire (Thu, 1-Oct 8:00 AM ET)
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Stryker trades on the NYSE stock market under the symbol SYK.
As of October 9, 2026, SYK stock price climbed to $277.33 with 1,365,692 million shares trading.
SYK has a beta of 0.42, meaning it tends to be less sensitive to market movements. SYK has a correlation of 0.03 to the broad based SPY ETF.
SYK has a market cap of $106.13 billion. This is considered a Large Cap stock.
Last quarter Stryker reported $7 billion in Revenue and $3.69 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.20.
In the last 3 years, SYK traded as high as $406.19 and as low as $249.98.
The top ETF exchange traded funds that SYK belongs to (by Net Assets): VTI, VOO, IVV, SPY, XLV.
SYK has underperformed the market in the last year with a return of -24.1%, while the SPY ETF gained +17.1%. In the last 3 month period, SYK fell short of the market, returning -14.9%, while SPY returned +3.8%. However, in the most recent 2 weeks SYK has outperformed the stock market by returning +2.1%, while SPY returned +0.9%.
SYK support price is $272.47 and resistance is $281.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SYK shares will trade within this expected range on the day.